| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A humanized monoclonal antibody targeting protein a promotes opsonophagocytosis of Staphylococcus aureus in human umbilical cord blood
|
Bernardino, Paola Nol
|
|
|
41 |
35 |
p. 5079-5084
|
artikel
|
| 2 |
Barriers to COVID-19 vaccination of migrant populations: A qualitative interview study of immunisation providers in Victoria, Australia
|
Tuckerman, Jane
|
|
|
41 |
35 |
p. 5085-5089
|
artikel
|
| 3 |
Beginning to address vaccine reluctance and refusal
|
Myers, Martin G.
|
|
|
41 |
35 |
p. 5063-5065
|
artikel
|
| 4 |
Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study
|
Mac, Stephen
|
|
|
41 |
35 |
p. 5141-5149
|
artikel
|
| 5 |
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives
|
Talotta, Rossella
|
|
|
41 |
35 |
p. 5182-5194
|
artikel
|
| 6 |
Editorial Board/Aims and Scope
|
|
|
|
41 |
35 |
p. IFC
|
artikel
|
| 7 |
Effectiveness of the strain 919 bovine ephemeral fever virus vaccine in the face of a real-world outbreak: A field study in Israeli dairy herds
|
Gleser, Dan
|
|
|
41 |
35 |
p. 5126-5133
|
artikel
|
| 8 |
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019
|
Minchin, Jamie
|
|
|
41 |
35 |
p. 5159-5181
|
artikel
|
| 9 |
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
|
Moros, Alexandra
|
|
|
41 |
35 |
p. 5072-5078
|
artikel
|
| 10 |
Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccines
|
Smith, William J.
|
|
|
41 |
35 |
p. 5113-5125
|
artikel
|
| 11 |
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study
|
Agrawal, Pankaj
|
|
|
41 |
35 |
p. 5195-5200
|
artikel
|
| 12 |
Quantitation of strain-specific hemagglutinin trimers in mosaic quadrivalent influenza nanoparticle vaccine by ELISA
|
Alabanza, Casper
|
|
|
41 |
35 |
p. 5201-5210
|
artikel
|
| 13 |
Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population
|
Lu, Xi
|
|
|
41 |
35 |
p. 5090-5096
|
artikel
|
| 14 |
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over
|
Kim, Seontae
|
|
|
41 |
35 |
p. 5066-5071
|
artikel
|
| 15 |
Social processes, practical issues, and COVID-19 vaccination among hesitant adults
|
Willis, Don E.
|
|
|
41 |
35 |
p. 5150-5158
|
artikel
|
| 16 |
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B.1.1.529 (Omicron) variant
|
Hu, Songhua
|
|
|
41 |
35 |
p. 5097-5112
|
artikel
|
| 17 |
Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design
|
Zimmerman, Richard K.
|
|
|
41 |
35 |
p. 5134-5140
|
artikel
|
Tijdschrift beschrijving